AbbVie supports disclosure and transparency on interactions between
the healthcare industry and healthcare professionals to ensure public
trust and confidence.
In alignment with the member companies of Medicines Australia,
AbbVie has undertaken to be open and transparent when we provide a
reportable payment to a healthcare professional or a third party as
directed by a healthcare professional. Reportable payments or
transfers of value are:
- Payments for the
provision of services such as giving a lecture, chairing an
educational meeting, providing advice as a member of an Advisory
Board or as a Consultant
- Airfares, accommodation and/or
conference registration fees to attend medical education or as part
of the provision of services.
AbbVie has prepared the report for publication in accordance with
the Medicines Australia Code of Conduct, Edition 18 and Australia’s
Privacy legislation. The report identifies healthcare professionals by
name where their consent has been provided. Where consent has not been
provided, the information is reported in aggregate.
From 1 October 2016, reporting of these payments is mandatory.
The report is designed to be read on this website. It is also
provided as a downloadable CSV file.
To comply with our privacy obligations, the report may be amended
from time to time. The report here contains the most up to date
information. Any use or disclosure of the data by a third party is the
responsibility of that third party, who must comply with the
Australian Privacy Act 1988.
For further information about the details in the report, please go
This report will be available for at least three years from the date
- Reporting Period from 1 May 2019 onward
- Reporting Periods after 1 November 2018
30 August 2019, this information will be held in a central
database, administered by Medicines Australia. This database is
designed to be searchable and includes an option to download the
data as a CSV file.
- For further
information about the details in the report, or to search the
database, please visit www.DisclosureAustralia.com.au
- Reporting Period 1 May 2018 to 31 October
- Reporting Period 1
November 2017 to 30 April 2018
- Reporting Period 1 May 2017 to 31
AbbVie collaborates and co-creates with the groups working with and
representing patients. The grants we provide patient groups to support
their ongoing work can be found here.
- Reporting Period 1
January 2017 to 31 December 2017 can be viewed by clicking here.
- Reporting Period 1 January 2018 to
31 December 2018 can be viewed by clicking here.
- Reporting Period 1 January
2019 to 31 December 2019 can be viewed by clicking here.
AbbVie engages with the Australian Government to participate, as
appropriate, in ongoing discussions on the healthcare environment,
including access to medicines and healthcare reform. AbbVie
contributes to these by sharing global knowledge, insights, and safety
and efficacy data, as appropriate, on relevant therapies. AbbVie does
not provide cash donations to political parties in Australia. As part
of our engagement with Government we attend and occasionally sponsor
political events and roundtable discussions where public policy on the
healthcare environment is discussed.
In 2017, our expenditure in attending political events was:
In 2018, our expenditure in attending political events
In 2019, our expenditure in attending political events
| || |